Streetbeat News

Products Services

XPON

Expion360, a lithium battery power solutions provider, will showcase its products for recreational vehicles (RVs) and light electric vehicles (LEVs) at the Overland Expo Pacific Northwest 2023.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:33 pm

GENI

Genius Sports (NYSE:GENI) has extended its exclusive low latency official data partnership with Football DataCo, covering the English Premier League, English Football League, and Scottish Professional Football League. The renewed partnership will run until the end of the 2024-2025 season. Additionally, Genius Sports' Second Spectrum AI-powered tracking technology will be expanded to the EFL Championship and Championship Play-Off matches.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:32 pm

WLDS

Wearable Devices (WLDS) has unveiled a new AI-based Air-Touch functionality for Android devices, allowing users to interact with their devices without physically touching the screen.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:32 pm

LLY

Eli Lilly and Company announced that its drug Jardiance has been recommended for the treatment of adults with chronic kidney disease in the EU. The CHMP of EMA granted a positive opinion, recommending Jardiance for this treatment.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:29 pm

GOOG

GOOGL

META

Meta Platforms plans to end access to news on Facebook and Instagram in Canada once the Online News Act, requiring internet firms to reimburse news publishers, comes into effect. The act forces platforms like Facebook and Google to negotiate commercial deals and pay news publishers for their content.

Portfolio Pulse from Anusuya Lahiri

June 23, 2023 | 12:18 pm

AMLX

Amylyx Pharmaceuticals received a negative opinion from the CHMP on its conditional marketing authorization application for AMX0035, a treatment for ALS in the EU. The company plans to seek re-examination of its application.

Portfolio Pulse from Bill Haddad

June 23, 2023 | 12:15 pm

GILD

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended Gilead Sciences' Trodelvy for pre-treated HR+/HER2- metastatic breast cancer.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:14 pm

BRDS

Bird Global, Inc. (NYSE:BRDS) has been awarded a new three-year permit to expand its e-scooter operations in Vienna, Austria. The permit allows Bird to double its fleet size, increase its operational area by 250%, and serve 120% more population. The expansion is based on Bird's focus on safety, sustainability, and technical innovation.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:07 pm

ABBV

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended AbbVie's Atogepant for the prophylaxis of migraine in adults with four or more migraine days per month.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:06 pm

SONN

Sonnet BioTherapeutics announced presentations at the 2023 Cytokine-Based Drug Development Summit and provided a preliminary update on the SON-080 study in chemotherapy-induced peripheral neuropathy. Seven patients have been enrolled, and doses have been tolerated well. The Data Safety Monitoring Board is expected to meet in Q3 2023.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:05 pm